SUBMISSION DEADLINE: SAME AS ABSTRACTS DEADLINE
The Early Career Investigator Award recognises contributions to the gene and cell therapy field and the impact of research carried out by early career researchers (from PhD through to 3 years post-doc). The awardee will present a plenary lecture at the ESGCT Annual Congress.
Eligibility Criteria
Nominees must be members of the ESGCT
All young investigators from PhD 3 years post-doc are eligible
Extension of this period may be allowed in case of eligible career breaks: maternity or paternity leave (1 year per child born after the PhD award); leave taken for long-term illness or national service; leave taken for unavoidable statutory reasons (e.g. clinical qualification). The cumulative eligibility period should not surpass 5 years following the award of the first PhD, unless the Board agrees they are the best candidate for the award.
For medical doctors, date of the clinical speciality completion is the time reference for calculation of the eligibility time-window. For MD and PhD, date of the PhD award takes precedence in the calculation of the eligibility time-window.
Nomination and Selection Process
Applicants must be nominated by two or more members of the ESGCT. Nominations should be sent to office@esgct.eu in writing no later than 20 June each year. Nomination letters should provide an overview of the candidate’s contributions to the field of gene therapy.
Nominations materials include:
Two or more nomination letters from members of ESGCT (up to 500 words)
Curriculum Vitae and bibliography of nominee
PDF copies of the applicant's two best papers
All nominations will be reviewed by the ESCGT Awards Selection Committee.
AWARD VALUE: €1000 and complimentary registration to the next annual congress